A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease (NCT06976268)
A Phase 2/3, Double-Blind, Placebo-Controlled Study of BHV-8000 in Participants With Early Parkinson's Disease
🩺 Plain-English Summary (8th-Grade Level)
A study to determine if BHV-8000 is efficacious, safe and tolerable in adults diagnosed with early Parkinson's disease. The study will consist of a 48-week double-blind treatment phase followed by a 48-week open-label phase.
Who can join: Review the eligibility criteria below.
Location: Site-049 — Birmingham, Alabama
Age range: 40 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (18 Sites)
- Site-049 — Birmingham, Alabama
- Site-041 — Los Angeles, California
- Site-025 — Aurora, Colorado
- Site-031 — Farmington, Connecticut
- Site-028 — New Haven, Connecticut
- Site-038 — Atlantis, Florida
- Site-017 — Boca Raton, Florida
- Site-051 — Maitland, Florida
- Site-027 — Chicago, Illinois
- Site-071 — Boston, Massachusetts
- Site-015 — Farmington Hills, Michigan
- Site-044 — Chesterfield, Missouri
- Site-006 — Albany, New York
- Site-005 — New York, New York
- Site-091 — Portland, Oregon
- Site-043 — Round Rock, Texas
- Site-074 — Newport News, Virginia
- Site-007 — Bellevue, Washington
📞 Contact the Study Coordinator
Phone: (203) 404-0410
Email: clinicaltrials@biohavenpharma.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Parkinson Disease
- Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation — Tucson, Arizona
- Parkinson's Disease Progression Study — Aurora, Colorado
- To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications — Birmingham, Alabama
- Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower) — Seattle, Washington
- Automated Imaging Differentiation of Parkinsonism — Birmingham, Alabama
- Study in Parkinson Disease of Exercise — Birmingham, Alabama
Explore by condition: All Parkinson Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.